{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T04:01:04Z","timestamp":1709956864859},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T00:00:00Z","timestamp":1433462400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s11912-015-0463-z","type":"journal-article","created":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T10:55:13Z","timestamp":1433415313000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["When Is It Safe to Omit Surgery in Primary Peritoneal Cancer With Small Volume Disease?"],"prefix":"10.1007","volume":"17","author":[{"given":"Rachel","family":"Pounds","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Kehoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,5]]},"reference":[{"key":"463_CR1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000362857","volume":"37","author":"O Unal","year":"2014","unstructured":"Unal O, Oztop I, Yazici O, Ozatli T, Ina A, Gunaydin Y, et al. Treatment and prognostic factors in primary peritoneal carcinoma: a multicenter study of the Anatolian Society of Medical Oncology (AMSO). Oncol Res Treat. 2014;37:332\u20138.","journal-title":"Oncol Res Treat"},{"issue":"1","key":"463_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00384-014-2029-1","volume":"30","author":"S Cao","year":"2015","unstructured":"Cao S, Jin S, Cao J, Shan J, Hu J, Che D, et al. Advances in malignant peritoneal mesothelioma. Int J Colorectal Dis. 2015;30(1):1\u201310.","journal-title":"Int J Colorectal Dis"},{"issue":"3","key":"463_CR3","first-page":"82","volume":"34","author":"F Moccia","year":"2013","unstructured":"Moccia F, Cummins M, Ciancia G, Rosetta G, Pascotto B, Morra I, et al. A case of extraovarian primary peritoneal carcinoma in an oophorectomized-hysterectomized patient: a diagnostic dilemma. G Chir. 2013;34(3):82\u20135.","journal-title":"G Chir"},{"issue":"2","key":"463_CR4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ygyno.2014.08.020","volume":"135","author":"T Schnack","year":"2014","unstructured":"Schnack T, Sorensen R, Nedergaard L, Hogdall C. Demographic clinical and prognostic characteristics of primary ovarian, peritoneal and tubal adenocarcinomas of serous histology\u2014a prospective comparative study. Gynecol Oncol. 2014;135(2):278\u201384. This large study identifies and compares patients with primary peritoneal cancer against those with ovarian and tubal cancer. PPC patients have a poorer outcome, more often have residual disease and suggest that PPC may be a distinct disease entity.","journal-title":"Gynecol Oncol"},{"issue":"7","key":"463_CR5","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10552-010-9525-6","volume":"21","author":"D Grant","year":"2010","unstructured":"Grant D, Moorman P, Akushevich L, Palmieri R, Bentley R, Schildkraut J. Primary peritoneal and ovarian cancers: an epidemiological comparative analysis. Cancer Causes Control. 2010;21(7):991\u20138.","journal-title":"Cancer Causes Control"},{"issue":"5","key":"463_CR6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1525-1438.2001.01027.x","volume":"11","author":"R Halperin","year":"2001","unstructured":"Halperin R, Zehavi S, Langer R, Hadas E, Bukovsky I, Schneider D. Primary peritoneal serous papillary carcinoma: a new epidemiological trend? A matched-case comparison with ovarian serious papillary cancer. Int J Gynecol Cancer. 2001;11(5):403\u20138.","journal-title":"Int J Gynecol Cancer"},{"key":"463_CR7","unstructured":"Primary peritoneal cancer. Cancer Research UK. 2014. http:\/\/www.cancerresearchuk.org\/about-cancer\/type\/rare-cancers\/rare-cancers-name\/primary-peritoneal-carcinoma . Accessed 12 May 2015"},{"issue":"1","key":"463_CR8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1158\/1055-9965.EPI-08-0771","volume":"18","author":"T Goodman","year":"2009","unstructured":"Goodman T, Shvetsov B. Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995\u20132004. Cancer Epidemiol Biomarkers Prev. 2009;18(1):132\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"463_CR9","unstructured":"Mesothelioma incidence statistics. Cancer Research UK. 2014. http:\/\/www.cancerresearchuk.org\/cancer-info\/cancerstats\/types\/Mesothelioma\/incidence\/incidence . Accessed 12 May 2015."},{"issue":"4","key":"463_CR10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jamcollsurg.2013.12.013","volume":"218","author":"E Levine","year":"2014","unstructured":"Levine E, Stewart J, Shen P, Russell G, Loggie B, Votanopoulos K. Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. J Am Coll Surg. 2014;218(4):573\u201385.","journal-title":"J Am Coll Surg"},{"issue":"1","key":"463_CR11","first-page":"407","volume":"34","author":"S Nasser","year":"2014","unstructured":"Nasser S, Arsenic R, Lohneis P, Kosian P, Sehouli J. A case of primary peritoneal carcinoma: evidence for a precursor in the fallopian tube. Anticancer Res. 2014;34(1):407\u201312.","journal-title":"Anticancer Res"},{"issue":"7","key":"463_CR12","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/ijc.23287","volume":"122","author":"S Jordan","year":"2008","unstructured":"Jordan S, Green A, Whiteman D, Moore S, Bain S, Gertig D, et al. Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis. Int J Cancer. 2008;122(7):1598\u2013603.","journal-title":"Int J Cancer"},{"issue":"13","key":"463_CR13","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1245\/s10434-014-3901-5","volume":"21","author":"Y Liu","year":"2014","unstructured":"Liu Y, Endo Y, Fujita T, Ishihashi H, Nishioka T, Canbay E, et al. Cytoreductive surgery under aminolevulinic acid-mediated photodynamic diagnosis plus hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from ovarian cancer and primary peritoneal carcinoma: results of a phase I trial. Ann Surg Oncol. 2014;21(13):4256\u201362.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"463_CR14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tjog.2012.10.003","volume":"52","author":"K Chao","year":"2013","unstructured":"Chao K, Chen Y, Juang C, Lau H, Wen K, Sung P, et al. Prognosis for advanced-stage primary peritoneal serious papillary carcinoma and serious ovarian cancer in Taiwan. Taiwan J Obstet Gynecol. 2013;52(1):81\u20134.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"3","key":"463_CR15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ygyno.2011.02.017","volume":"121","author":"K Schmeler","year":"2011","unstructured":"Schmeler K, Sun C, Malpica A, Dealers M, Bodurka D, Bershenson. Low-grade serous primary peritoneal carcinoma. Gynecol Oncol. 2011;121(3):482\u20136.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"463_CR16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000338402","volume":"5","author":"R Kawaguchi","year":"2012","unstructured":"Kawaguchi R, Tanase Y, Haruta S, Nagai A, Yoshida S, Furukawa N, et al. Paclitaxel plus carboplatin chemotherapy for primary peritoneal carcinoma: a study of 22 cases and comparison with stage III-IV ovarian serous carcinoma. Case Rep Oncol. 2012;5(1):173\u201380.","journal-title":"Case Rep Oncol"},{"issue":"2","key":"463_CR17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ajog.2007.07.003","volume":"198","author":"E Eisenhauer","year":"2008","unstructured":"Eisenhauer E, Sonoda Y, Levine D, Abu-Rustum N, Gemignani M, Sabbatini P. Platinum resistance and impaired survival in patients with advanced primary peritoneal carcinoma: matched-case comparison with patients with epithelial ovarian carcinoma. Am J Obstet Gynecol. 2008;198(2):213.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"463_CR18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.critrevonc.2009.10.003","volume":"75","author":"G Pentheroudakis","year":"2010","unstructured":"Pentheroudakis G, Pavlidis N. Serous papillary peritoneal carcinoma: unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review. Crit Rev Oncol Hematol. 2010;75(1):27\u201342.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"463_CR19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ygyno.2013.12.002","volume":"132","author":"V Costa Miranda da","year":"2015","unstructured":"da Costa Miranda V, de Souza Fede A, Dos Anjos C, da Silva J, S\u00e1nchez F, da Silva Bess L, et al. Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: safety and effectiveness. Genesco\u2019 Oncol. 2015;132(2):287\u201391.","journal-title":"Genesco\u2019 Oncol"},{"issue":"1","key":"463_CR20","first-page":"56","volume":"33","author":"F Yang","year":"2012","unstructured":"Yang F, Wang J, Li H, Tong X. Prognosis of primary peritoneal carcinoma: effect of cytoreductive surgery combined with neoadjuvant chemotherapy after laparoscopic diagnosis and evaluation: a multi-center trial. Eur J Gynaecol Oncol. 2012;33(1):56\u20139.","journal-title":"Eur J Gynaecol Oncol"},{"issue":"7","key":"463_CR21","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ejso.2013.02.018","volume":"39","author":"N Bakrin","year":"2013","unstructured":"Bakrin N, Billy F, Baratti D, Bereder J, Quenet F, Lorimier G, et al. Primary peritoneal serous carcinoma treated by cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. A multi-institutional study of 36 patients. Eur J Surg Oncol. 2013;39(7):742\u20137.","journal-title":"Eur J Surg Oncol"},{"key":"463_CR22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jviscsurg.2014.07.005","volume":"5","author":"N Bakrin","year":"2014","unstructured":"Bakrin N, Classes J, Pomel C, Gouy S, Chene G, Glehen O. Hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer. J Visc Surg. 2014;5:347\u201353.","journal-title":"J Visc Surg"},{"issue":"4","key":"463_CR23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/PGP.0b013e31826a629b","volume":"32","author":"L Horn","year":"2013","unstructured":"Horn L, Kafkova S, Leonhardt K, Kellner C, Einenkel J. Serious tubal in situ carcinoma (STIC) in primary peritoneal serous carcinomas. Int J Gynecol Pathol. 2013;32(4):339\u201344. In recent years there has been a growing body of evidence that some, though maybe not all, ovarian high grade serous carcinomas are derived from the distal end of the fallopian tube. Here the authors describe their findings in the context of peritoneal cancers.","journal-title":"Int J Gynecol Pathol"},{"issue":"5","key":"463_CR24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PGP.0b013e3182a142c2","volume":"33","author":"E Colon","year":"2014","unstructured":"Colon E, Carlson J. Evaluation of the fallopian tubes after neoadjuvant chemotherapy: persistence of serous tubal intraepithelial carcinoma. Int J Gynecol Pathol. 2014;33(5):433\u20139.","journal-title":"Int J Gynecol Pathol"},{"issue":"8","key":"463_CR25","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/IGC.0b013e31826a3559","volume":"22","author":"M Luyckx","year":"2012","unstructured":"Luyckx M, Leblanc E, Fullerton T, Morice P, Darai E, et al. Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a retrospective French multicentric study. Int J Gynecol Cancer. 2012;22(8):1337\u201343.","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"463_CR26","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","volume":"363","author":"I Vergote","year":"2010","unstructured":"Vergote I, Trop\u00e9 CG, Amant F, Kristensen GB, Ehlen T, Johnson N, et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med. 2010;363(10):943\u201353.","journal-title":"N Engl J Med"},{"key":"463_CR27","unstructured":"Kehoe S, Hook J, Nankivell M, Jayson GC, Kitchener HC, Lopes T et al. Chemotherapy or upfront surgery for newly diagnosed advanced ovarian cancer: Results from the MRC CHORUS trial. Lancet. 2015. A confirmatory study which shows that a primary chemotherapeutic approach to the ovarian\/peritoneal type tumours is feasible and does not adversely affect mortality, and reduces treatment side effect. This was in bulky disease, and in non-bulky the omission of surgery could be argud."},{"issue":"5","key":"463_CR28","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.20.5.1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20(5):1248\u201359.","journal-title":"J Clin Oncol"},{"key":"463_CR29","volume":"8","author":"A Elattar","year":"2011","unstructured":"Elattar A, Bryant A, Winter-Roach BA, Hatem M, Naik R. Optimal primary surgical treatment for advanced epithelial ovarian cancer. Cochrane Database Syst Rev. 2011;8, CD007565.","journal-title":"Cochrane Database Syst Rev"},{"key":"463_CR30","first-page":"101","volume":"42","author":"CT Griffiths","year":"1975","unstructured":"Griffiths CT. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr. 1975;42:101\u20134.","journal-title":"Natl Cancer Inst Monogr"},{"issue":"10","key":"463_CR31","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJM199503093321002","volume":"332","author":"ME Burg van der","year":"1995","unstructured":"van der Burg ME, van Lent M, Buyse M, Kobierska A, Colombo N, Favalli G, et al. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med. 1995;332(10):629\u201334.","journal-title":"N Engl J Med"},{"issue":"24","key":"463_CR32","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1056\/NEJMoa041125","volume":"351","author":"PG Rose","year":"2004","unstructured":"Rose PG, Nerenstone S, Brady MF, Clarke-Pearson D, Olt G, Rubin SC. Secondary surgical cytoreduction for advanced ovarian carcinoma. N Engl J Med. 2004;351(24):2489\u201397.","journal-title":"N Engl J Med"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-015-0463-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11912-015-0463-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-015-0463-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:31:47Z","timestamp":1559421107000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11912-015-0463-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,5]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["463"],"URL":"https:\/\/doi.org\/10.1007\/s11912-015-0463-z","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,5]]},"article-number":"36"}}